Zach Hornby, Boundless CEO

Bound­less Bio rais­es $105M in ef­fort to reimag­ine tar­get­ed can­cer ther­a­py

Bound­less Bio CEO Zach Horn­by was sit­ting in his La Jol­la, CA of­fice last fall, prepar­ing for a board meet­ing when his com­put­er pinged with an email. It was his CSO, Chris Has­sig, email­ing over ta­bles and charts at the best pos­si­ble time.

Their new type of can­cer treat­ment was work­ing. In mice, at least.

“This was a cat­alyt­ic event,” Horn­by told End­points News. The da­ta “re­al­ly said, ‘yes, we can do this.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.